Flexible solutions designed for
biotech companies
Your milestones. Your needs. Your team.
IQVIA Biotech’s
Suite of Solutions
IQVIA Biotech provides flexible, tailored, integrated clinical and commercial solutions designed to help smaller biotech companies move forward in their effort to get treatments to patients – from defining the plan for their asset, to trial design and implementation, through launch and commercialization – all while delivering compelling results to investors, stakeholders and regulatory authorities with confidence.
Click on each circle to learn more about our suite of integrated clinical and commercial solutions.
Asset valuation
& due diligence
Drug development strategy & analytics
Clinical
Development
Launch strategy & planning
Commercialization & lifecycle management
The Value Creation Continuum
Advancing Asset Value Across Milestones
On the surface, your milestones may look the same as large pharma’s. But we know that you face very different questions along your journey. The answers to those questions can impact not only your product’s probability of success, but that of your overall company.
Touch anywhere on the path to learn more about the questions and relevant solutions we provide along the continuum.
Pre-IND
Phase I
Phase II/III
Product Launch
Commercialization & Lifestyle Management
Pre-IND
IND Submission
First in Human,
Proof of Principle
Study
Initiated
Results
Commercialization
Decision
Managed Care Agreements and/or Pricing Announced
FDA or
Regulatory Approval
Guideline
Adoption
Online Growth
and Lifecycle Management
Insights & Resources
Insights & resources library
Learn more about IQVIA Biotech
IQVIA.com careers privacy policy
Copyright © 2019 IQVIA Biotech. All rights reserved.
Therapeutic expertise
Clinical development expertise
Clinical development Home
Leadership team
Clinical development
Insights & resources
Contact us
Contact Us
Asset valuation
& due diligence
Understand — and articulate — the market value of your asset
As you progress through the various stages of drug development and commercialization, you’ll be addressing how your asset brings value to the industry, your stakeholders and your company.
Working together, we can help you harness the power of human ingenuity, scientific rigor and unrivalled data and analytics to develop clearer views of your asset’s value and your timelines – with the ultimate goal of strengthening your position in deal discussions and negotiations and advancing the value of your asset.
Ways we can help
Early assessment
of product feasibility
01
Deal option
and structure assessment
02
Value proposition and pitch materials
03
Download white paper
Capturing the attention of investors
Contact Us FOr
More infoRmation
Drug development
strategy & analytics
Aligning your strategy to critical
market drivers
When you understand the specific landscape and market for your product, you can develop a long-term strategy to help avoid costly amendments down the road. Incorporating real world data into your clinical development plan supports decision-making throughout the drug development process, boosting confidence in your selected path forward. This comprehensive plan will provide a roadmap for key activities – including cost and timeline factors – for your investors and key stakeholders.
Ways we can help
Therapeutic
area strategy
01
Regulatory
strategy and plan
02
Clinical development strategy
03
Watch webinar:
Capturing the attention
of investors: How to create a compelling value story
Contact Us FOr
More infoRmation
Launch strategy
& planning
Forging a path to product launch
When you develop a comprehensive plan with a well-defined brand, value, and channel strategy, you can secure market access and establish a path to optimal product launch. IQVIA Biotech’s proven launch strategies and connected insights, refined from over 5,000 launches, can provide you with the insights and resources to help you develop a market-backed, evidence-driven commercial plan.
Ways we can help
Opportunity
assessment
01
Launch planning,
tracking and management
02
Brand
strategy and development
03
Read blog post
Creating a framework
for a successful launch
Contact Us FOr
More infoRmation
Commercialization &
lifecycle management
Optimizing commercial execution
Accelerate the time to implementation, launch and maintain your business, and adjust rapidly post-launch. We can help you streamline your operations and gain valuable visibility into market forces. Let our global and local healthcare and functional experts provide you with the actionable insights and resources to help you accelerate your commercial success and get your product into the hands of the patients who need it.
Ways we can help
Opportunity
assessment
01
Launch planning,
tracking and management
02
Brand
strategy and development
03
Watch webinar:
Commercializing on your own:
A panel discussion with insights from emerging biopharma executives
Contact Us FOr
More infoRmation
Commercialization & lifecycle managemenrt
Launch strategy & planning
Clinical
development
Drug development strategy &
analytics
Asset valuation
& due diligence
Early assessment of product feasibility
01
Deal option and structure assessment
02
Value proposition and pitch materials
03
Ways we can help
Contact Us FOr
More infoRmation
Download white paper
Capturing the attention of investors
As you progress through the various stages
of drug development and commercialization, you’ll be addressing how your asset brings value to the industry, your stakeholders
and your company. Working together, we can help you harness the power of human ingenuity, scientific rigor and unrivalled data and analytics to develop clearer views of your asset’s value and your timelines – with the ultimate goal of strengthening your position in deal discussions and negotiations and advancing the value of your asset.
Understand — and articulate — the market value of your asset
Asset valuation & due diligence
Commercialization & lifecycle managemenrt
Launch strategy & planning
Clinical
development
Drug development strategy &
analytics
Asset valuation
& due diligence
Therapeutic area strategy
01
Regulatory strategy and plan
02
Clinical development strategy
03
Ways we can help
Contact Us FOr
More infoRmation
Watch webinar:
Capturing the attention of investors:
How to create a compelling value story
When you understand the specific landscape and market for your product, you can develop
a long-term strategy to help avoid costly amendments down the road. Incorporating real world data into your clinical development plan supports decision-making throughout the drug development process, boosting confidence in your selected path forward. This comprehensive plan will provide a roadmap for key activities – including cost and timeline factors – for your investors and key stakeholders.
Aligning your strategy to critical market drivers
Drug development strategy & analytics
Commercialization & Lifecycle Managemenrt
Launch Strategy & Planning
Clinical
Development
Drug Development Strategy & Analytics
Asset Valuation
& Due Diligence
Commercialization & lifecycle managemenrt
Launch strategy & planning
Clinical
development
Drug development strategy &
analytics
Asset valuation
& due diligence
Opportunity assessment
01
Launch planning, tracking and management
02
Brand strategy and development
03
Ways we can help
Contact Us FOr
More infoRmation
Read blog post
Creating a framework for a successful launch
When you develop a comprehensive plan with a well-defined brand, value, and channel strategy, you can secure market access and establish a path to optimal product launch. IQVIA Biotech’s proven launch strategies and connected insights, refined from over 5,000 launches, can provide you with the insights and resources to help you develop a market-backed, evidence-driven commercial plan.
Forging a path to product launch
Launch strategy & planning
Commercialization & lifecycle managemenrt
Launch strategy & planning
Clinical
development
Drug development strategy &
analytics
Asset valuation
& due diligence
Multi-channel marketing implementation and tracking
01
Pricing and market access strategy and local implementation
02
Trade, compliance and transparency
03
Ways we can help
Contact Us FOr
More infoRmation
Watch webinar:
Commercializing on your own:
A panel discussion with insights from emerging biopharma executives
Accelerate the time to implementation, launch and maintain your business, and adjust rapidly post-launch. We can help you streamline your operations and gain valuable visibility into market forces.
Let our global and local healthcare and functional experts provide you with the actionable insights and resources to help you accelerate your commercial success and get your product into the hands of
the patients who need it.
Optimizing commercial execution
Commercialization & lifecycle management
Commercialization
Lifecycle Management
Guideline
Adoption
Ongoing Growth and Lifecycle Management
Your Challenges
What sales channels should I employ?
How do I reach the right prescribers?
What’s the best way to engage with patients?
Should I outsource commercial capabilities or build them in-house?
When should I start thinking about expanding product usage and labeling?
How do I ensure compliance with various regulatory agencies?
Our Solutions
Asset Valuation
& Due Diligence
Drug Development Strategy & Analytics
Clinical Development
Launch Strategy
& Planning
Commercialization
& Lifecycle Management
LEARN MORE
about our relevant solutions
Product Launch
Close
Close
Product Launch
Managed Care Agreements and/or Pricing Announced
FDA or Regulatory Approval
Your Challenges
What's the best way to take my product to market?
Where should I launch, and in what order?
How do I determine an optimal pricing and distribution strategy?
Do I have access to the right data and technology platforms to track my product's performance?
Our Solutions
Asset Valuation
& Due Diligence
Drug Development Strategy & Analytics
Clinical Development
Launch Strategy
& Planning
Commercialization
& Lifecycle Management
LEARN MORE
about our relevant solutions
Commercialization
Lifecycle Management
Phase II/III
Close
Close
Phase II/III
Study Initiated
Results
Commercialization
Decision
Your Challenges
How can I avoid costly protocol amendments?
What's the best way to get sites up and running quickly?
What vendors do I need and how do I manage them?
How can I optimize my burn rate?
How can I get to my next milestone more quickly?
Should I sell, partner or take the product to market on my own?
Our Solutions
Asset Valuation
& Due Diligence
Drug Development Strategy & Analytics
Clinical Development
Launch Strategy
& Planning
Commercialization
& Lifecycle Management
LEARN MORE
about our relevant solutions
Product Launch
Phase I
Close
Close
Phase I
First in Human
Proof of Principle
Your Challenges
What can I do to demonstrate the value of my asset, and ultimately the valuation of my company?
What should be included in my Target Product Profile (TPP)?
Why is a Clinical Development Plan (CDP) important to investors and key stakeholders?
When should I start thinking about the specific landscape and market opportunity for my product?
Our Solutions
Asset Valuation
& Due Diligence
Drug Development Strategy & Analytics
Clinical Development
Launch Strategy
& Planning
Commercialization
& Lifecycle Management
LEARN MORE
about our relevant solutions
Phase II/III
Pre-IND
Close
Close
Pre-IND
Pre-IND
IND Submission
Your Challenges
How do I drive investor discussions for optimal outcomes?
How do I define and frame the value of my asset to create a differentiated value story?
Is there anything I can now do to mitigate regulatory risk and risk to my overall development path?
Our Solutions
Asset Valuation
& Due Diligence
Drug Development Strategy & Analytics
Clinical Development
Launch Strategy
& Planning
Commercialization
& Lifecycle Management
LEARN MORE
about our relevant solutions
Phase I
Close
Close
Flexible solutions designed for
biotech companies
Your milestones. Your needs. Your team.
IQVIA Biotech provides flexible, tailored, integrated clinical and commercial solutions designed to help smaller biotech companies move forward in their effort to get treatments to patients – from defining the plan for their asset, to trial design and implementation, through launch and commercialization – all while delivering compelling results to investors, stakeholders and regulatory authorities with confidence.
IQVIA Biotech’s Suite of Solutions
Click on each circle to learn more about our suite of integrated clinical and commercial solutions.
Asset valuation
& due diligence
Drug development strategy & analytics
Clinical
Development
Launch strategy & planning
Commercialization & lifecycle management
Asset valuation
& due diligence
Drug development strategy & analytics
Clinical development
Launch strategy & planning
Commercialization & lifecycle management
The Value Creation Continuum
Advancing Asset Value Across Milestones
On the surface, your milestones may look the same as large pharma’s. But we know that you face very different questions along your journey. The answers to those questions can impact not only your product’s probability of success, but that of your overall company.
Click on the path to learn more about the questions and relevant solutions we provide along the continuum.
Pre-IND
Phase I
Phase II/III
Product Launch
Commercialization
& Lifecycle Management
Pre-IND
IND Submission
First in Human
Proof of Principle
Rare Disease Designation
Study
Initiated
Interim Analysis
In-house Database Lock
Results
Study Initiated
In-house Database Lock
Commercialization Decision
Completion
File NDA
FDA or Regulatory Approval
Managed Care Agreements and/or Pricing Announced
Guideline Adoption
Ongoing Growth and Lifecycle Management
Phase II
Phase III
Pre-IND
Pre-IND
IND Submission
First in Human
Proof of Principle
Phase I
Study
Initiated
Interim Analysis
In-house Database Lock
Results
Study Initiated
In-house Database Lock
Commercialization Decision
Completion
Phase II/III
Phase II
Phase III
FDA or Regulatory Approval
Managed Care Agreements and/or Pricing Announced
Product Launch
Guideline Adoption
Ongoing Growth and Lifecycle Management
Commercialization
& Lifecycle Management
Insights & Resources
DOWNLOAD WHITE PAPER
LEARN ABOUT THE EVENT
SCHEDULE A MEETING
Where is IQVIA Biotech?
Join us at:
2020 AAD Annual Meeting
Denver, CO
March 20-24, 2020
Insights & resources library
Learn more about IQVIA Biotech
IQVIA.com careers privacy policy
Copyright © 2019 IQVIA Biotech. All rights reserved.
Clinical development
Insights & resources
Contact us
Contact us
Insights & resources
Therapeutic expertise
Leadership team
Clinical development
Clinical development expertise
Contact Us
Pre-IND
Your Challenges
How do I drive investor discussions for optimal outcomes?
How do I define and frame the value of my asset to create a differentiated value story?
Is there anything I can now do to mitigate regulatory risk and risk to my overall development path?
Our Solutions
Asset Valuation
& Due Diligence
Drug Development Strategy & Analytics
Clinical Development
Launch Strategy & Planning
Commercialization
& Lifecycle Management
LEARN MORE
about our relevant solutions
Phase I
Your Challenges
What can I do to demonstrate the value of my asset, and ultimately the valuation of my company?
What should be included in my Target Product Profile (TPP)?
Why is a Clinical Development Plan (CDP) important to investors and key stakeholders?
When should I start thinking about the specific landscape and market opportunity for my product?
Our Solutions
Asset Valuation
& Due Diligence
Drug Development Strategy & Analytics
Clinical Development
Launch Strategy & Planning
Commercialization
& Lifecycle Management
LEARN MORE
about our relevant solutions
Phase II/III
Your Challenges
How can I avoid costly protocol amendments?
What’s the best way to get sites up and running quickly?
What vendors do I need and how do I manage them?
How can I optimize my burn rate?
How can I get to my next milestone more quickly?
Should I sell, partner or take the product to market on my own?
Our Solutions
Asset Valuation
& Due Diligence
Drug Development Strategy & Analytics
Clinical Development
Launch Strategy & Planning
Commercialization
& Lifecycle Management
LEARN MORE
about our relevant solutions
Product Launch
Your Challenges
What’s the best way to take my product to market?
Where should I launch, and in what order?
How do I determine an optimal pricing and distribution strategy?
Do I have access to the right data and technology platforms to track my product’s performance?
Our Solutions
Asset Valuation
& Due Diligence
Drug Development Strategy & Analytics
Clinical Development
Launch Strategy & Planning
Commercialization
& Lifecycle Management
LEARN MORE
about our relevant solutions
Commercialization & Lifecycle Management
Your Challenges
What sales channels should I employ?
How do I reach the right prescribers?
What’s the best way to engage with patients?
Should I outsource commercial capabilities or build them in-house?
When should I start thinking about expanding product usage and labeling?
How do I ensure compliance with various regulatory agencies?
Our Solutions
Asset Valuation
& Due Diligence
Drug Development Strategy & Analytics
Clinical Development
Launch Strategy & Planning
Commercialization
& Lifecycle Management
LEARN MORE
about our relevant solutions
Launch strategy & planning
Commercialization & lifecycle management
Clinical
development
Drug development strategy & analytics
Asset valuation & due diligence
Understand — and articulate — the market value of your asset
Ways we can help
Contact Us FOr
More infoRmation
Download white paper
Capturing the attention of investors
Asset valuation
& due diligence
As you progress through the various stages of drug development and commercialization, you’ll be addressing how your asset brings value to the industry, your stakeholders and your company.
Working together, we can help you harness the power of human ingenuity, scientific rigor and unrivalled data and analytics to develop clearer views of your asset’s value and your timelines – with the ultimate goal of strengthening your position in deal discussions and negotiations and advancing the value of your asset.
Early assessment of product feasibility
01
Deal option and structure assessment
02
Value proposition
and pitch materials
03
Launch strategy & planning
Commercialization & lifecycle management
Clinical
development
Asset valuation
& due diligence
Drug development strategy & analytics
Aligning your strategy to critical market drivers
Drug development strategy & analytics
Ways we can help
Contact Us FOr
More infoRmation
Watch webinar:
Capturing the attention
of investors: How to create a compelling value story
When you understand the specific landscape and market for your product, you can develop a long-term strategy to help avoid costly amendments down the road. Incorporating real world data into your clinical development plan supports decision-making throughout the drug development process, boosting confidence in your selected path forward. This comprehensive plan will provide a roadmap for key activities – including cost and timeline factors – for your investors and key stakeholders.
Therapeutic
area strategy
01
Regulatory
strategy and plan
02
Clinical development strategy
03
Commercialization & lifecycle management
Clinical
development
Drug development strategy & analytics
Asset valuation
& due diligence
Launch strategy & planning
Forging a path to product launch
Launch strategy & planning
Ways we can help
Contact Us FOr
More infoRmation
When you develop a comprehensive plan with a well-defined brand, value, and channel strategy, you can secure market access and establish a path to optimal product launch. IQVIA Biotech’s proven launch strategies and connected insights, refined from over 5,000 launches, can provide you with the insights and resources to help you develop a market-backed, evidence-driven commercial plan.
Opportunity
assessment
01
Launch planning,
tracking and management
02
Brand strategy
and development
03
Read blog post
Creating a framework for a successful launch
Launch strategy & planning
Clinical
development
Drug development strategy & analytics
Asset valuation
& due diligence
Commercialization & lifecycle management
Optimizing commercial execution
Commercialization & lifecycle management
Ways we can help
Contact Us FOr
More infoRmation
Watch webinar:
Commercializing
on your own:
A panel discussion with insights from emerging biopharma executives
Accelerate the time to implementation, launch and maintain your business, and adjust rapidly post-launch. We can help you streamline your operations and gain valuable visibility into market forces.
Let our global and local healthcare and functional experts provide you with the actionable insights and resources to help you accelerate your commercial success and get your product into the hands of
the patients who need it.
Multi-channel marketing implementation
and tracking
01
Pricing and market access strategy and local implementation
02
Trade, compliance
and transparency
03
Read blog post
DOWNLOAD WHITE PAPER
LEARN ABOUT the event
SCHEDULE A MEETING
Read blog post
Where is IQVIA Biotech?
Join us at:
The 6th Annual Dermatology Innovation Forum
Denver, CO
March 19, 2020
LEARN ABOUT the event
Where is IQVIA Biotech?
Join us at:
2020 Dermatology Summit San Francisco, CA
January 12, 2020
LEARN ABOUT the event
Where is IQVIA Biotech?
Join us at:
Outsourcing in Clinical Trials New England - Boston, MA
October 2-3, 2019
LEARN ABOUT the event
Where is IQVIA Biotech?
Join us at:
Annual Meeting & Exposition of the American Society of Hematology (ASH)
Orlando, Florida
December 7-10, 2019
LEARN ABOUT the event
Where is IQVIA Biotech?
Join us at:
2020 Dermatology Summit
San Francisco, CA
January 12, 2020